Higene Biopharmaceutical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Higene Biopharmaceutical General Information

Description

Developer of marine biomedicine. The company focuses on the development and utilization of "blue drug library", it has taken the lead in screening a batch of "semi-mature" marine innovative drugs with clear efficacy, clear intellectual property rights, and reliable safety assessment data, helping to realize the aggregation development and cascade output of marine biomedicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C, No. 23
  • Hong Kong East Road, Laoshan District
  • Qingdao, Shandong
  • China
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Building C, No. 23
  • Hong Kong East Road, Laoshan District
  • Qingdao, Shandong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Higene Biopharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 11-Mar-2022 Completed Startup
1. Joint Venture 25-Jul-2019 Completed Startup
To view Higene Biopharmaceutical’s complete valuation and funding history, request access »

Higene Biopharmaceutical Patents

Higene Biopharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240327418-A1 Multi-target inhibitor targeting hdac and nad synthesis and use of multi-target inhibitor Pending 04-Aug-2021
WO-2023011416-A1 Multi-target inhibitor targeting hdac and nad synthesis and use of multi-target inhibitor Inactive 04-Aug-2021
JP-2024528251-A Multi-targeted inhibitors targeting hdac and nad synthesis and their uses Pending 04-Aug-2021 A61K31/343

Higene Biopharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qingdao Jufeng Technology Venture Investment Venture Capital Minority
Rongshuhai Private Equity Fund Management (Zhuhai) Venture Capital Minority
Qingdao Huanghai Pharmaceutical Corporation Minority
Qingdao Marine Biomedical Research Institute Venture Capital Minority
To view Higene Biopharmaceutical’s complete investors history, request access »

Higene Biopharmaceutical FAQs

  • When was Higene Biopharmaceutical founded?

    Higene Biopharmaceutical was founded in 2019.

  • Where is Higene Biopharmaceutical headquartered?

    Higene Biopharmaceutical is headquartered in Qingdao, China.

  • What industry is Higene Biopharmaceutical in?

    Higene Biopharmaceutical’s primary industry is Drug Discovery.

  • Is Higene Biopharmaceutical a private or public company?

    Higene Biopharmaceutical is a Private company.

  • What is Higene Biopharmaceutical’s current revenue?

    The current revenue for Higene Biopharmaceutical is .

  • Who are Higene Biopharmaceutical’s investors?

    Qingdao Jufeng Technology Venture Investment, Rongshuhai Private Equity Fund Management (Zhuhai), Qingdao Huanghai Pharmaceutical, and Qingdao Marine Biomedical Research Institute have invested in Higene Biopharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process